Femasys Inc income statement

In fiscal 2025, Femasys Inc reported revenue of $2.3m, up 40.8% on the year before, operating income of −$17.6m (a -767.0% margin) and net income of −$18.6m, or −$0.47 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Femasys Inc: income statement, annual
Fiscal year	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Revenue	1	1	1	1	2	2	2
Cost of revenue	0	0	0	0	1	1	1
Gross profit	1	1	1	1	1	1	1
Research and development	4	4	6	7	8	8	6
Selling and marketing	0	0	1	1	4	4	5
General and administrative	3	4	5	7	6	7	7
Operating income	−7	−8	−12	−15	−18	−18	−18
Interest expense	0	0	0	0	2	2	1
Income before tax	−7	−8	−11	−14	−19	−19	−12
Income tax	0	0	0	0	0	0	0
Net income	−7	−8	−11	−14	−19	−19	−12
Diluted EPS	−$7.20	−$1.12	−$0.96	−$0.93	−$0.85	−$0.47	—
Diluted shares (average)	—	7m	12m	15m	22m	40m	—
EBITDA	−6	−8	−11	−14	−17	−17	−17

US$ thousands unless shown otherwise. Fiscal quarters.

Femasys Inc: income statement, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Revenue	555	582	341	409	729	813	425	332
Cost of revenue	191	192	117	158	294	303	159	142
Gross profit	364	389	224	251	436	510	266	189
Research and development	2,303	2,167	2,968	1,414	1,382	1,813	1,309	1,947
Selling and marketing	1,572	1,182	909	985	1,144	1,406	1,316	1,294
General and administrative	1,531	1,681	1,723	1,617	1,478	1,829	1,782	1,932
Operating income	−5,118	−4,723	−5,461	−3,852	−3,654	−4,623	−4,224	−5,066
Interest expense	413	440	459	492	532	408	177	186
Income before tax	−5,408	−5,113	−5,901	−4,586	−4,195	−3,945	846	−4,468
Income tax	1	10	−4	0	0	5	0	1
Net income	−5,409	−5,124	−5,897	−4,586	−4,195	−3,950	846	−4,469
Diluted EPS	−$4.80	−$0.23	−$0.23	−$3.18	−$2.00	−$0.01	$0.00	−$1.33
EBITDA	−5,042	−4,640	−5,376	−3,765	−3,568	−4,538	−4,141	−4,983

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: FEMY vs VNRX FEMY vs ICU FEMY vs IMDX

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Femasys Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Femasys Inc.